FDA won't enforce name change for sunscreens.

* The Food and Drug Administration (FDA) announced it will not take enforcement action against sunscreen manufacturers who could not re-label products with the required name changes by Sept. 1. The name changes are required for four active ingredients: meradimate for methyl anthranilate, octinoxate for octyl methoxycinnamate, octisalate for octyl salicylate and ensulizole for phenylbenzimidazole sulfonic acid. The agency stated enforcement discretion, "is appropriate to avoid the need for drug manufacturers and distributors to incur extraordinary expenses in implementing the labeling changes immediately or to cease marketing certain drug products whose labeling cannot be changed in a timely manner." The agency said the technical amendment has no impact on the statutory requirement to comply with the name changes.